Voyager Therapeutics to Present VY1706 Study Design at CTAD 2026
The presentation concerns the design of Voyager's VY1706 Alzheimer's gene therapy study; no study results are reported.
The presentation concerns the design of Voyager's VY1706 Alzheimer's gene therapy study; no study results are reported.